CUSIP: 92244V104
Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STK
-
Total 13F shares
-
12,165,210
-
Share change
-
-390,321
-
Total reported value
-
$8,728,910
-
Price per share
-
$0.72
-
Number of holders
-
56
-
Value change
-
-$302,039
-
Number of buys
-
17
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP 92244V104?
CUSIP 92244V104 identifies VAXX - VAXXINITY INC - COMMON STK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2024
-
Previous quarter:
Q4 2023
Recent filing periods for CUSIP 92244V104:
Institutional Holders of VAXXINITY INC - COMMON STK (VAXX) as of Q1 2024
As of 31 Mar 2024,
VAXXINITY INC - COMMON STK (VAXX) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,165,210 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, Creative Planning, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Pathstone Holdings, LLC, and Stelac Advisory Services LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.